NCT00323154View on ClinicalTrials.gov

Nalbuphine for the Treatment of Opioid Induced Pruritus in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Pruritis
Interventions
DRUG

Nalbuphine

Trial Locations (1)

Unknown

British Columbia's Children's Hospital, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT00323154 - Nalbuphine for the Treatment of Opioid Induced Pruritus in Children | Biotech Hunter | Biotech Hunter